Leadless Versus Transvenous Pacing: Propensity‐Matched 12‐Month Outcomes
Pacing and Clinical Electrophysiology · 11.11.2026
DOI: 10.1111/pace.70502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 11.11.2026. Verfasst von Xiaoxiao Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Chengdu Fifth People's Hospital, Chengdu, Sichuan, China. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Chengdu Municipal Health Commission, Traditional Chinese Medicine Research Special Project of the Sichuan Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Leadless pacemakers avoid the subcutaneous pocket and transvenous lead required for conventional pacing, but comparative real‐world evidence in patients at high cardiorenal risk remains limited.
Methods
We conducted a single‐center retrospective cohort study of de novo permanent pacemaker recipients between January 2021 and December 2024. The source cohort comprised 150 leadless and 410 transvenous pacemaker recipients. After 1:2 propensity score matching, 150 and 300 patients, respectively, were analyzed. The primary endpoint was the first occurrence of a prespecified 12‐month device‐related complication composite. A prespecified analysis evaluated patients aged 65 years or older with type 2 diabetes mellitus and chronic kidney disease.
Results
The primary endpoint occurred in 6.7% of leadless and 14.0% of transvenous recipients (risk ratio, 0.48; 95% confidence interval, 0.25–0.92; p = 0.028), an absolute difference of 7.3 percentage points (95% confidence interval, 1.1–12.6). The time‐to‐event association was similar (hazard ratio, 0.45; 95% confidence interval, 0.23–0.90; p = 0.024) and remained consistent after parsimonious adjustment and competing‐risk analysis. The difference was mainly driven by pocket‐, lead‐, and thoracic access‐related events. After pocket‐ and lead‐specific events were excluded, serious complication rates were 5.3% in both groups. Findings in the older diabetes plus chronic kidney disease subgroup were directionally consistent but imprecise.
Conclusions
The observed advantage of leadless pacing was primarily structural, reflecting avoidance of complications inherent to the transvenous pocket‐and‐lead system. Non‐pocket/non‐lead serious complications were similar between groups.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Chengdu Fifth People's Hospital, Chengdu, Sichuan, China.
Förderung
- Chengdu Municipal Health Commission
- Traditional Chinese Medicine Research Special Project of the Sichuan Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Cheng, X., Tang, N., & Zhang, D. (2026). Leadless Versus Transvenous Pacing: Propensity‐Matched 12‐Month Outcomes. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70502
Vancouver
Cheng X, Tang N, Zhang D. Leadless Versus Transvenous Pacing: Propensity‐Matched 12‐Month Outcomes. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70502
BibTeX
@article{Cheng2026,
author = {Cheng, Xiaoxiao and Tang, Nian and Zhang, Denghong},
title = {Leadless Versus Transvenous Pacing: Propensity‐Matched 12‐Month Outcomes},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70502}
}
EUVIMED